BioCardia Inc. (BCDA)
NASDAQ: BCDA
· Real-Time Price · USD
2.06
0.02 (0.98%)
At close: Sep 05, 2025, 3:59 PM
2.08
0.97%
After-hours: Sep 05, 2025, 04:24 PM EDT
0.98% (1D)
| Bid | 1.99 |
| Market Cap | 11.95M |
| Revenue (ttm) | 58K |
| Net Income (ttm) | -8.79M |
| EPS (ttm) | -1.68 |
| PE Ratio (ttm) | -1.23 |
| Forward PE | -2.04 |
| Analyst | Buy |
| Ask | 2.12 |
| Volume | 27,405 |
| Avg. Volume (20D) | 303,845 |
| Open | 2.01 |
| Previous Close | 2.04 |
| Day's Range | 1.99 - 2.09 |
| 52-Week Range | 1.63 - 3.26 |
| Beta | 0.81 |
About BCDA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCDA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-16.25%
BioCardia shares are trading lower after the compa...
Unlock content with
Pro Subscription
7 months ago
+3.65%
BioCardia shares are trading higher after the company announced that the American College of Cardiology 2025 Scientific Sessions accepted the presentation for the results of the double-blind randomized placebo-controlled CardiAMP HF Phase 3 study.
